Kohli, JD; Goldberg, LI; Nichols, DE. Dopamine vascular actions of N-substituted derivatives of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN). Eur. J. Pharmacol., 1 Jun 1979, 56 (1–2), 39–44. 454 kB. https://doi.org/10.1016/0014-2999(79)90430-8 #ADTN
Nichols, DE. The development of novel dopamine agents. In Dopamine Receptors; Kaiser, C; Kebabian, JW, Eds., American Chemical Society, Washington, DC, 29 Jun 1983; Vol. 224, pp 201–221. 1.9 MB. https://doi.org/10.1021/bk-1983-0224.ch009 #X
3,4-Methylenedioxyamphetamine · EA-1298 · MDA
N-Me-MDPEA · Homarylamine · MDMPEA · METHYL-H · METHYL-MDPEA
4-Methoxycathinone · PMA-βk
N,N-DMMDBA · N,N-Dimethylpiperonylamine
2,3-MDMPEA · N-Methyl-2,3-methylenedioxyphenethylamine
β-Me-MDPEA · β-Methyl-3,4-methylenedioxyphenethylamine
3,4-Ethylenedioxyphenethylamine · EDPEA
2-HO-5,N-MePEA-βk · β-Keto-2-hydroxy-5,N-dimethylphenethylamine
2-M-5-MePEA-βk · β-Keto-2-methoxy-5-methylphenethylamine
3-Ac-4-HPEA · 3-Acetyl-4-hydroxyphenethylamine
4-HO-MC · 4-Hydroxymethcathinone
Norhydroxytolyl-mephedrone
4-Carboxyamphetamine · 4-HOOC-A
7,8-Dihydroxy-2-methyl-THIQ
6,7-Dihydroxy-2-methyl-THIQ